Discovery of Widespread Metabolic Enzymes on Human DNA Unveils New Layer of Nuclear Biology and Cancer Mechanisms
Budi Oetomo Narendra A groundbreaking study published in Nature Communications has fundamentally reshaped our understanding of cellular architecture,...
Breaking Oncology News & General Research
Oregon Health & Science University Breakthrough Unveils Novel Molecule SU212 Offering Hope for Aggressive Triple-Negative Breast Cancer and Beyond
Researchers at Oregon Health & Science University (OHSU) have achieved a significant milestone in the...
Mass General Brigham Study Suggests Vitamin D Unlikely to Mitigate Acute COVID-19 Severity but Warrants Further Investigation for Long COVID Outcomes
Findings from a comprehensive study spearheaded by Mass General Brigham indicate that while high doses...
AI finally tests a century old theory about how cancer begins
In a significant leap forward for oncology research, scientists at EMBL Heidelberg have unveiled a...
Yale Researchers Uncover Long-Sought Mechanism of Essential Metabolic Molecule Transport into Mitochondria, Opening New Avenues for Disease Treatment
The human body, a complex symphony of chemical reactions, relies on a crucial molecule derived...
A “mirror” molecule can starve cancer cells without harming healthy cells
The conventional arsenal against cancer, including chemotherapy and radiation, primarily functions by attacking rapidly dividing...
New iron nanomaterial wipes out cancer cells without harming healthy tissue
The Oregon State Breakthrough: A New Era in Chemodynamic Therapy The core of this transformative...
Unraveling the Paradox: How Polyamines Drive Both Healthy Aging and Aggressive Cancer Growth
Polyamines, ubiquitous molecules present in all living cells, have long captivated scientific interest due to...
Deciphering T Cell Fate: New Genetic Mechanisms Unveiled to Reverse Exhaustion and Enhance Cancer Immunotherapy.
Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC...
Dr. Vinay Prasad, Controversial Head of FDA’s Vaccines and Biologics Division, Confirmed to Depart Agency Amidst Scrutiny
admin Dr. Vinay Prasad, a figure known for his outspoken critical analyses within the medical community...
